The Committee’s investigation has determined that conflict of interest rules employed by the FDA and the CDC have been weak, enforcement has been lax, and committee members with substantial ties to pharmaceutical companies have been given waivers to participate in committee proceedings. https://vaccinesafetycommission.org/pdfs/Conflicts-Govt-Reform.pdf